TERUMO CORP (TUO DU) stock market data APIs
€12.4098
-0.01(-0.1%)
as of September 16, 2026
Try our APIs with
free plan!
TERUMO CORP Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for TUO.DU.
Prev. Close
12.4098
Open
12.4034
High
12.4624
Low
12.233
52 wk Range
10.12-14.5921
Market Cap
27 604 M
EPS
-0.01
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get TERUMO CORP data using free add-ons & libraries
Get TERUMO CORP Fundamental Data
TERUMO CORP Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2018-06-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
TERUMO CORP News
New
NICE Supports Routine NHS Funding and Access to Ex-Situ Machine Perfusion in a Major Step Forward for Liver Transplantation
ORGANOX LIMITED National Institute for Health and Care Excellence (NICE) guidance supports wider patient access to life-saving liver transplantation through routine adoption of machine perfusion tech...
Terumo Corp (TRUMF) (Q1 2027) Earnings Call Highlights: Record Revenue and Profit Surge on ...
This article first appeared on GuruFocus. Release Date: August 07, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Record ...
Global Apheresis Market to Reach USD 4.41 Billion by 2031, Driven by Plasma-Based Therapies and Automated Technologies
Company Logo Disposables lead the product segment, while plasmapheresis holds the largest procedure share. North America dominates the market. Key players include Terumo, Fresenius, Haemonetics, BD a...
Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway
For Immediate Release Chicago, IL – July 21, 2026 – Today, Zacks Equity Research discusses Terumo TRUMY, QuidelOrtho QDEL, Lumexa Imaging Holdings, Inc. LMRI and Brainsway BWAY. Industry: Medica...
Get TERUMO CORP fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
